Company profile
c-LEcta company profile
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.
Business identity
- Website
- https://www.c-lecta.com
- Contact email
- [email protected]
- Phone number
- 49-341-3552140
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00101-00250 employees
- Revenue range
- $10K+
- Founded
- 2004-01-01
Headquarters
- Headquarters
- Leipzig, Saxony, Germany
- Postal code
- 04103
- Country code
- DE
- Continent
- Europe